Saltar al contenido
Dispositivos y mediciónArtículo de investigación3 min read

Smartwatch AF algorithms caught most post-ablation recurrences in simulation

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Wearable smartwatches for atrial fibrillation detection and burden estimation after ablation: comparison with continuous monitoring. · Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026 · Artículo original ↗

Idea principal

Simulating three smartwatch algorithms on continuous implant data from 346 ablation patients, sensitivity for atrial fibrillation (AF) recurrence was 64.4% to 82.2%, and AF burden correlated with the implant above r = 0.97. These are simulated watches applied to recorded data, not people wearing watches in daily life.

Study design

Artículo de investigación

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

After catheter ablation for atrial fibrillation, doctors need to know whether the arrhythmia comes back and how much of the time it is present. Smartwatches can screen for AF, but how well they track recurrence and burden after ablation was uncertain. The authors compared simulated smartwatch algorithms with implantable cardiac monitors (ICMs).

Población y método

Using continuous ICM recordings from 346 patients in the CIRCA-DOSE trial, the authors simulated three commercial smartwatch algorithms (Apple Watch AF Burden, Apple Watch irregular rhythm notifications (IRN) and Fitbit irregular heart rhythm detection (IHRD)), assuming the watch is worn from 8:00 AM to 10:00 p.m. They also simulated common intermittent rhythm-monitoring strategies. Primary endpoints were sensitivity for recurrence and correlation with ICM-derived AF burden, stratified by daily wear time and patient activity.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    AF recurred in 47.1% of patients. Simulated sensitivity for recurrence was 82.2% (Apple Watch AF Burden), 70.6% (Apple Watch IRN) and 64.4% (Fitbit IHRD), versus 15.8% to 64.6% for simulated intermittent monitors; wearables outperformed Holter and patch strategies.
  2. 2
    AF burden from each algorithm correlated with ICM-derived burden above r = 0.97.
  3. 3
    Among recurrences the watches missed, the median AF burden was below 0.02%.
  4. 4
    Longer wear helped: sensitivity exceeded 90% with 24-hour use, while patient activity modestly reduced detection.

Límites e incertidumbre

  1. 1
    The watches were simulated from implant data under an assumed 8:00 AM to 10:00 p.m. wear schedule, so real-world wear, signal quality and missed readings are not tested.
  2. 2
    Participants came from one ablation trial, so the results may not apply to other AF patients or procedures.
  3. 3
    Even the best algorithm missed nearly one in five recurrences at daytime wear, and the abstract gives no confidence intervals for sensitivity.
  4. 4
    This reading rests on the abstract only.

Relevancia práctica

The results suggest a smartwatch could complement, though not replace, formal monitoring after ablation, and wearing it more hours would catch more episodes. Missed episodes were mostly very short. If you have had an ablation, ask your cardiology team how to use any watch alerts, and do not stop prescribed monitoring.

Tus datos

If you wear a watch with AF detection, keep it on as many hours as practical, including overnight if the battery and comfort allow, and use the same device over time. Share the logged alerts and any burden summary with your clinician instead of interpreting a single notification alone.

Cómo interpretar la evidencia

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Aims

Wearable ECG-enabled smartwatches have been validated for atrial fibrillation (AF) screening, but their accuracy for monitoring AF recurrence and quantifying AF burden after catheter ablation is uncertain. To evaluate the simulated performance of three commercial smartwatch algorithms for AF recurrence detection and AF burden estimation compared with implantable cardiac monitors (ICMs).

Methods and results

Using continuous ICM data from 346 patients in the CIRCA-DOSE trial, we simulated three smartwatch algorithms, assuming daytime wear (8:00 AM-10:00 p.m.). We also simulated commonly-used non-invasive intermittent rhythm monitoring strategies. Primary endpoints were sensitivity for arrhythmia recurrence and correlation with ICM-derived AF burden. Analyses were stratified by daily wear time and patient activity. AF recurrence occurred in 47.1% of patients. Simulated detection sensitivities were 82.2% (Apple Watch AF Burden), 70.6% (Apple Watch IRN), and 64.4% (Fitbit IHRD), compared with 15.8-64.6% for simulated intermittent AECG monitors. Wearables outperformed commonly-used Holter/patch monitoring strategies. AF burden correlation with ICM exceeded r = 0.97 for all algorithms. Among missed recurrences, median AF burden was <0.02%. Longer daily wear improved sensitivity (>90% with 24-hour use), whereas patient activity modestly reduced detection.

Conclusion

Smartwatch-based AF detection algorithms demonstrate strong correlation with ICM-derived AF burden and clinically good sensitivity for recurrence detection, outperforming conventional non-invasive strategies. These findings support the integration of wearables as a scalable alternative for post-ablation rhythm monitoring.

Fuentes y atribución

Wearable smartwatches for atrial fibrillation detection and burden estimation after ablation: comparison with continuous monitoring.

Aguilar M, Macle L, Chamieh R, Khairy P, Deyell MW, Bennett RG, Andrade JG.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026-09-01

DOI: 10.1093/europace/euaf280 ↗PubMed · 41208416 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Estudio de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explicaciones detalladasLeer estudio →
·Revisión de revisiones

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explicaciones detalladasLeer estudio →
Dispositivos y medición →